– SWITZERLAND, Zurich – Microcaps AG, a Zurich-based company developing a new gold standard in microencapsulation, today announced the appointment of Dr. Dragan Grabulovski and Ronald Kogens to its Board as Independent Directors.
“I am extremely happy with the newly appointed members, each of them possesses an expertise that will be essential as we continue to grow and penetrate the market with our proprietary microencapsulation platform. These are very exciting times to become involved with Microcaps.” said Board Chair, Hanne de Mora.
About Dr. Dragan Grabulovski
Dr. Dragan Grabulovski is the former co-founder and CSO of Covagen. Since 2015, he has worked as a biotech consultant and serial entrepreneur.
Dr. Dragan Grabulovski said: “I am impressed by the versatility of Microcaps’ technology, it is truly fascinating to explore the wide range of benefits Microcaps can bring, from injectable treatments, probiotic delivery, to flavor and fragrance delivery. I am thrilled to be part of this journey.”
About Ronald Kogens
Ronald Kogens is a partner and tech lawyer at Froriep, a Swiss-based law firm. He specializes in VC-financing and financial market law with a focus on early-stage, disruptive technologies, and life science.
Ronald Kogens added: “I am very excited to join Microcaps and I look forward to contributing to the creation of a strong portfolio of products. Microcaps may introduce a paradigm shift in the way microcapsules are controlled, delivered, and released throughout multiple industries.”
Founded in early 2019, the ETH Zürich based tech startup Microcaps will bring Swiss precision to the world of microencapsulation. The company’s unique and patented technology allows it to fabricate microcapsules at an unmatched precision and efficiency providing its customers with tailored microencapsulation solutions. The technology has its largest impact potential in the fields of pharmaceuticals, nutrition, and cosmetics.
For information, visit www.microcaps.ch
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.